Table II.
Baseline characteristics of participants.
| Characteristics | RRMS (n=60) | Control (n=64) | P-value |
|---|---|---|---|
| Sex (male/female) | 14/46 | 22/42 | 0.679 |
| Age (years) | 30.4±8.9 | 36.7±12.2 | 0.003 |
| BMI (kg/m2) | 26.4±5.31 | 29.5±5.8 | 0.140 |
| Mean blood | 107.2±10.38 | 96.6±16.14 | 0.089 |
| pressure (mmHg) | |||
| Disease duration (years) | 6.33±4.5 | - | |
| EDSS | 4.8±7.1 | - | |
| Medication | |||
| Rebif | 12 | ||
| Glienya | 13 | ||
| Betaferon | 8 | ||
| Avonex | 15 | ||
| Tysabri | 12 | ||
Data are presented as number for categorical data or the means ± standard deviation (SD) for parametrically distributed data. RRMS, relapse-remitting multiple sclerosis; BMI, body mass index; EDSS, expanded disability status scale.